217 related articles for article (PubMed ID: 22277251)
21. Caveolin-1 is a negative regulator of MMP-1 gene expression in human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling pathway.
Haines P; Samuel GH; Cohen H; Trojanowska M; Bujor AM
J Dermatol Sci; 2011 Dec; 64(3):210-6. PubMed ID: 21925842
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy.
Araoka T; Abe H; Tominaga T; Mima A; Matsubara T; Murakami T; Kishi S; Nagai K; Doi T
Mol Cells; 2010 Sep; 30(3):209-18. PubMed ID: 20803090
[TBL] [Abstract][Full Text] [Related]
23. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
25. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.
Bujor AM; Nakerakanti S; Morris E; Hant FN; Trojanowska M
Exp Dermatol; 2010 Apr; 19(4):347-54. PubMed ID: 20201953
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling.
Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H
Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
28. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
[TBL] [Abstract][Full Text] [Related]
29. Smad7 and protein phosphatase 1alpha are critical determinants in the duration of TGF-beta/ALK1 signaling in endothelial cells.
Valdimarsdottir G; Goumans MJ; Itoh F; Itoh S; Heldin CH; ten Dijke P
BMC Cell Biol; 2006 Mar; 7():16. PubMed ID: 16571110
[TBL] [Abstract][Full Text] [Related]
30. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of cell functions by CSD peptide subdomains.
Reese C; Dyer S; Perry B; Bonner M; Oates J; Hofbauer A; Sessa W; Bernatchez P; Visconti RP; Zhang J; Hatfield CM; Silver RM; Hoffman S; Tourkina E
Respir Res; 2013 Sep; 14(1):90. PubMed ID: 24011378
[TBL] [Abstract][Full Text] [Related]
32. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
33. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
35. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
[TBL] [Abstract][Full Text] [Related]
36. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.
Leask A; Sa S; Holmes A; Shiwen X; Black CM; Abraham DJ
Mol Pathol; 2001 Jun; 54(3):180-3. PubMed ID: 11376132
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.
Piera-Velazquez S; Makul A; Jiménez SA
Arthritis Rheumatol; 2015 Oct; 67(10):2749-58. PubMed ID: 26096997
[TBL] [Abstract][Full Text] [Related]
38. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
[TBL] [Abstract][Full Text] [Related]
39. Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis.
Castello-Cros R; Whitaker-Menezes D; Molchansky A; Purkins G; Soslowsky LJ; Beason DP; Sotgia F; Iozzo RV; Lisanti MP
Cell Cycle; 2011 Jul; 10(13):2140-50. PubMed ID: 21670602
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
